NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Geron Corp Share Price Chart

O H L

Geron Corp Performance Overview

Days Range
$1.30Low
$1.32High

Markets Today

Previous Close$1.32
Open$1.32
Volume1,405,619
Day's Range$1.30 - $1.32
52W Range$1.04 - $2.01
Market Cap$828.79 M

Historical Performance

1M Returns-13.73
3M Returns+4.76
6M Returns-14.84
1Y Returns0.00
5Y Returns-6.38
10Y Returns-34.00

Geron Corp Fundamentals

Market Cap$828.79 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$183.88 M
ROE TTM-0.33
EPS TTM$-0.10
Quarterly Earnings Growth YOYN/A
PB Ratio3.79
EBITDA$-51.08 M
Profit Margin-45.41
Market Cap$828.79 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$183.88 M
ROE TTM-0.33
EPS TTM$-0.10
Quarterly Earnings Growth YOYN/A
PB Ratio3.79
EBITDA$-51.08 M
Profit Margin-45.41

Geron Corp Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$39.60 M$49.04 M$47.23 M$48.02 M$51.84 M$57.48 M
Gross Profit +$38.40 M$47.85 M$47.23 M$48.02 M$50.15 M$48.24 M
Operating Income -$16.70 M-$12.45 M-$13.89 M-$25.54 M$158.00 K-$12.50 M
EBITDA -$16.57 M-$12.33 M-$13.76 M-$8.42 M-$102.00 K-$12.52 M
Interest Expense -$8.20 M-$8.52 M-$8.64 M-$7.30 M-$7.15 M-$7.15 M
Depreciation $131.00 K$128.00 K$128.00 K$17.12 M-$260.00 K-$21.00 K
Income Before Tax -$19.84 M-$16.38 M-$18.43 M-$28.86 M-$3.64 M-$16.68 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$19.84 M-$16.38 M-$18.43 M-$28.86 M-$3.64 M-$16.68 M
Net Profit Margin -50.08%-33.39%-39.02%-60.11%-7.03%-29.02%

Geron Corp Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $637.00 K$638.00 K$638.00 K$640.00 K$641.00 K$642.00 K
Reserve & Surplus -$1.79 B-$1.81 B-$1.83 B-$1.86 B-$1.86 B-$1.88 B
Non-Current Liabilities $231.18 M$231.38 M$230.96 M$233.13 M$231.44 M$230.06 M
Current Liabilities $63.03 M$64.28 M$87.71 M$111.54 M$73.57 M$70.33 M
Total Liabilities $294.21 M$295.67 M$318.68 M$344.67 M$305.01 M$300.39 M
Fixed Assets $1.15 M$1.19 M$973.00 K$884.00 K$1.00 M$1.09 M
Current Assets $495.77 M$505.60 M$522.34 M$520.27 M$498.53 M$486.34 M
Total Assets $562.45 M$555.20 M$567.38 M$570.54 M$534.12 M$519.01 M

Geron Corp Cash Flow

Dec 2025Dec 2025Mar 2026Mar 2026Jun 2026Jun 2026
Net Income -$28.86 M-$28.86 M-$3.64 M-$3.64 M-$16.68 M-$16.68 M
Operating Cash Flow -$22.07 M-$22.07 M-$62.91 M-$62.91 M-$15.83 M-$15.83 M
Investing Cash Flow $21.14 M$21.14 M$51.86 M$51.86 M$8.29 M$8.29 M
Financing Cash Flow $378.00 K$378.00 K$2.42 M$2.42 M$1.38 M$1.38 M
Change in Cash -$553.00 K-$553.00 K-$8.66 M-$8.66 M-$6.25 M-$6.25 M

Geron Corp Peer Comparison

CompanyMarket Cap5 Years Return %PE RatioProfit Margin %Dividend Yield %
ALKS
$7.73B55.13%119.7016.37%0.00%

Geron Corp Return Calculator

The Geron Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$9,291
Invested Amount$10,000
Est. Returns$-709
Invest in USA Stock Today

About Geron Corp

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

FAQs

Geron Corp (GERN) share price as of September 18, 2026 is $1.31. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Geron Corp (GERN) Share by opening an international trading account with Angel One.
Purchasing Geron Corp (GERN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Geron Corp (GERN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Geron Corp (GERN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Geron Corp on September 18, 2026, is $828.79 M.
Geron Corp operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Geron Corp (GERN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91